185 related articles for article (PubMed ID: 6280605)
1. Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drug.
Brigden D; Fiddian P; Rosling AE; Ravenscroft T
Antiviral Res; 1981 Nov; 1(4):203-12. PubMed ID: 6280605
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of antiviral activities of acyclovir in vitro and in vivo.
Collins P
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():19-27. PubMed ID: 6313598
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir.
Appelboom TM; Flowers FP
South Med J; 1983 Jul; 76(7):905-9. PubMed ID: 6306847
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro and in vivo antiherpes virus activities of the acyclic nucleosides, acyclovir (Zovirax) and 9-[(2-hydroxy-1-hydroxymethylethoxy)methyl]guanine (BWB759U).
Collins P; Oliver NM
Antiviral Res; 1985 Jun; 5(3):145-56. PubMed ID: 2992369
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of herpes virus isolates from acyclovir clinical trials.
Collins P; Appleyard G; Oliver NM
Am J Med; 1982 Jul; 73(1A):380-2. PubMed ID: 6285727
[TBL] [Abstract][Full Text] [Related]
6. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.
Schaeffer HJ; Beauchamp L; de Miranda P; Elion GB; Bauer DJ; Collins P
Nature; 1978 Apr; 272(5654):583-5. PubMed ID: 205792
[TBL] [Abstract][Full Text] [Related]
7. Acyclovir and other chemotherapy for herpes group viral infections.
Balfour HH
Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661
[TBL] [Abstract][Full Text] [Related]
8. Acyclovir.
Lancet; 1981 Oct; 2(8251):845-6. PubMed ID: 6116957
[No Abstract] [Full Text] [Related]
9. Acyclovir and herpesvirus infections. A review of the literature.
Pallasch TJ; Joseph CE; Gill CJ
Oral Surg Oral Med Oral Pathol; 1984 Jan; 57(1):41-4. PubMed ID: 6320078
[TBL] [Abstract][Full Text] [Related]
10. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
[TBL] [Abstract][Full Text] [Related]
11. Promising new antiherpes agent being tested in humans.
JAMA; 1978 Nov; 240(21):2231. PubMed ID: 212617
[No Abstract] [Full Text] [Related]
12. Emerging therapies for herpes viral infections (types 1 - 8).
Chakrabarty A; Pang KR; Wu JJ; Narvaez J; Rauser M; Huang DB; Beutner KR; Tyring SK
Expert Opin Emerg Drugs; 2004 Nov; 9(2):237-56. PubMed ID: 15571482
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
Safrin S
Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
[No Abstract] [Full Text] [Related]
15. Acyclovir--a promising antiviral agent: a review of the preclinical and clinical data in ocular herpes simplex management.
Koliopoulos J
Ann Ophthalmol; 1984 Jan; 16(1):19-24. PubMed ID: 6322661
[TBL] [Abstract][Full Text] [Related]
16. 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent.
Martin JC; Dvorak CA; Smee DF; Matthews TR; Verheyden JP
J Med Chem; 1983 May; 26(5):759-61. PubMed ID: 6302255
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir. Pharmacology and clinical experience.
Laskin OL
Arch Intern Med; 1984 Jun; 144(6):1241-6. PubMed ID: 6329117
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir: an update of the clinical applications of this antiherpes agent.
Fiddian AP; Brigden D; Yeo JM; Hickmott EA
Antiviral Res; 1984 Jun; 4(3):99-117. PubMed ID: 6089659
[TBL] [Abstract][Full Text] [Related]
19. Viral sensitivity following the introduction of acyclovir.
Collins P
Am J Med; 1988 Aug; 85(2A):129-34. PubMed ID: 2841855
[TBL] [Abstract][Full Text] [Related]
20. Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
Neyts J; Naesens L; Ying C; De Bolle L; De Clercq E
Antiviral Res; 2001 Feb; 49(2):115-20. PubMed ID: 11248363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
